journal articles
CORRIGENDUM TO “REAL-WORLD LONG-TERM CONTINUATION OF LECANEMAB THERAPY AND THE CLINICAL UTILITY OF PHOSPHORYLATED TAU 181” [THE JOURNAL OF PREVENTION OF ALZHEIMER\'S DISEASE (2026) 100664]
Moeko Noguchi-Shinohara, Daiki Muramatsu, Ayano Shima, Yasuhiro Sakashita, Yasutake Tada, Hiroki Yamaguchi, Junji Komatsu, Tokuhei Ikeda, Kenjiro Ono
CITATION:
Moeko Noguchi-Shinohara ; Daiki Muramatsu ; Ayano Shima ; Yasuhiro Sakashita ; Yasutake Tada ; Hiroki Yamaguchi ; Junji Komatsu ; Tokuhei Ikeda ; Kenjiro Ono: Corrigendum to “Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181” [The Journal of Prevention of Alzheimer's Disease (2026) 100664]. The Journal of Prevention of Alzheimer’s Disease (JPAD). http://dx.doi.org/10.1016/j.tjpad.2026.100668